Drugs / Evafolimab
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06279754 | Feb → Jun 2024 | non-small cell squamous lung carcinoma | The First Affiliated Hospital of Xinxiang Medical College | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Evafolimab | “Evafolimab Injection：Subcutaneous injection on day 1, 8, and 15, once every three weeks cycle” NCT06279754 ↗ |
| Route | Subcutaneous | “Subcutaneous injection on day 1, 8, and 15” NCT06279754 ↗ |